5AM Opportunities II, L.P.
Insider CIK 1844401 · CAMP 10% owner · ARTV 10% owner · CINC 10% owner · LTGO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 3,152,305 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,823,238 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 866,018 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,484,401 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-12 | 4,975,543 | — | $0 | 4,975,543 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-12 | 2,350,419 | — | $0 | 2,350,419 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,484,401 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 866,018 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 1,823,238 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion deriv | 2026-08-10 | 2026-08-12 | 3,152,305 | — | $0 | 0 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-12 | 2,350,419 | — | — | 2,350,419 | SEC↗ |
| LTGO Latigo Biotherapeutics, In | C Conversion | 2026-08-10 | 2026-08-12 | 4,975,543 | — | — | 4,975,543 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy deriv | 2026-08-03 | 2026-08-05 | 3,179,558 | $1.53 | $4.86M | 3,179,558 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy deriv | 2026-08-03 | 2026-08-05 | 3,179,558 | $1.53 | $4.86M | 3,179,558 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2025-09-11 | 2025-09-15 | 2,941,176 | $1.53 | $4.50M | 2,941,176 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 4,244,770 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 3,395,816 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 15,002,166 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2024-10-15 | 2024-10-15 | 909,090 | $11.00 | $10.00M | 2,625,145 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 302,770 | — | $0 | 302,770 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 1,716,055 | — | $0 | 1,716,055 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 843,592 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion deriv | 2024-07-22 | 2024-07-24 | 214,692 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2024-07-22 | 2024-07-24 | 833,333 | $12.00 | $10.00M | 1,182,054 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | C Conversion | 2024-07-22 | 2024-07-24 | 1,058,284 | — | $0 | 1,058,284 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | J Other | 2024-07-22 | 2024-07-24 | 112,966 | $10.20 | $1.15M | 1,171,250 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | J Other | 2024-07-22 | 2024-07-24 | 348,721 | $10.20 | $3.56M | 348,721 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-28 | 496,323 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-28 | 3,953,990 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-28 | 487,333 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-08-15 | 2022-08-17 | 112,667 | $30.00 | $3.38M | 3,953,990 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-08-15 | 2022-08-17 | 487,333 | $30.00 | $14.62M | 487,333 | SEC↗ |